Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Member Directory
- HDA History
- Industry Recognition
- Staff Directory
- Diversity, Equity & Inclusion
- Executive Committee
- Mission
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- Membership
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Pharmacy Services Administrative Organizations
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Product Availability
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Advocacy
- Healthcare Affordability
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Conference and Expo
- PCSC Educational Seminar
- Business and Leadership Conference
- Webinars
- Annual Board and Membership Meeting
- Speaker Resource Center
- Traceability Seminar
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

Faces of the Supply Chain

HDA's video series spotlights the passionate, committed and innovative individuals who make the supply chain work.

Prepare for DSCSA Compliance

Download HDA’s complimentary resources on bar coding, exceptions handling, EPCIS and more to prepare for the 2023 traceability law deadline.

Download

2022 Traceability Seminar

HDA's annual DSCSA-focused event will take place in Washington, D.C. on October 12-14.

Karen J. Ribler Scholarship

Graduate-level supply chain scholars are encouraged to apply for the HDA Research Foundation's Scholarship Program.

Learn More

FEATURED UPCOMING EVENTS

2022 Traceability Seminar

October 12 to 14, 2022 | Marriott Marquis, Washington, D.C.

HDA’s annual Traceability Seminar brings together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones as well as innovative approaches and lessons learned as distributors,...

View All Events

MEMBER SPOTLIGHT

Henry Schein, Inc. (NASDAQ: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500^® Company and a member of the S&P 500^® and the NASDAQ 100^® indexes, Henry Schein employs nearly 19,000 Team Schein Members and serves more than one million customers.

Learn More

IN THE NEWS

June 7, 2022

Greg Drew, RPh, of Value Drug Honored With 2022 Nexus Award for Lifetime Achievement

June 7, 2022

HDA Recognizes Pharmaceutical and Consumer Product Manufacturers with DIANA Awards

March 17, 2022

Rx Supply Chain Progressing on EPCIS Adoption for DSCSA, Yet Challenges Still Remain

View All News

ISSUES IN DISTRIBUTION

Pharmaceutical Traceability

HDA and the healthcare distribution industry have led on federal traceability issues for nearly two decades. This work culminated in the passage of the Drug Supply Chain Security Act (DSCSA) in 2013. The...

Healthcare Affordability

With HDA distributors providing between $33–$53 billion in cost savings to the U.S. healthcare economy each year, our industry is committed to improving access to lower-cost, high-quality medicines for...

Prescription Drug Abuse and Diversion

HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious...

Importation of Prescription Medicines

HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit...